These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1774829)

  • 1. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Khachadurian AK; Shimamura T; Rozovski SJ; Ananthakrishnan R; Armenian B; Coly E; alHinai A; Martucci C; Schneider SH; Amorosa LF
    Jpn Heart J; 1991 Sep; 32(5):675-85. PubMed ID: 1774829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
    Shiomi M; Ito T; Tsukada T; Yata T; Watanabe Y; Tsujita Y; Fukami M; Fukushige J; Hosokawa T; Tamura A
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1938-44. PubMed ID: 7583574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cholesterol reduction on the endothelial function and progression of atherosclerosis in WHHL rabbits.
    Kroon AA; Stalenhoef AF; Buikema H; Demacker PN; de Wilde PC; Leijten PA; van Gilst WH
    Atherosclerosis; 1993 Nov; 103(2):221-30. PubMed ID: 8292097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
    Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits.
    Watanabe Y; Ito T; Shiomi M; Tsujita Y; Kuroda M; Arai M; Fukami M; Tamura A
    Biochim Biophys Acta; 1988 Jun; 960(3):294-302. PubMed ID: 3132979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
    Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins.
    Hofnagel O; Luechtenborg B; Eschert H; Weissen-Plenz G; Severs NJ; Robenek H
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):604-10. PubMed ID: 16373606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis.
    Atkinson JB; Hoover RL; Berry KK; Swift LL
    Atherosclerosis; 1989 Aug; 78(2-3):123-36. PubMed ID: 2783197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year.
    Harsch M; Braesen JH; Niendorf A
    Atherosclerosis; 1997 Feb; 128(2):139-47. PubMed ID: 9050770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
    Shiomi M; Ito T
    Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dietary omega-3 fatty acid on serum lipids, platelet function, and atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Clubb FJ; Schmitz JM; Butler MM; Buja LM; Willerson JT; Campbell WB
    Arteriosclerosis; 1989; 9(4):529-37. PubMed ID: 2751481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and cardiovascular pathology of heterozygous Watanabe heritable hyperlipidaemic rabbits treated with pravastatin and probucol on a low-cholesterol (0.03%)-enriched diet.
    Bräsen JH; Harsch M; Niendorf A
    Virchows Arch; 1998 Jun; 432(6):557-62. PubMed ID: 9672198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of pravastatin sodium alone and in combination with cholestyramine on hepatic, intestinal and adrenal low density lipoprotein receptors in homozygous Watanabe heritable hyperlipidemic rabbits.
    Kuroda M; Matsumoto A; Itakura H; Watanabe Y; Ito T; Shiomi M; Fukushige J; Nara F; Fukami M; Tsujita Y
    Jpn J Pharmacol; 1992 May; 59(1):65-70. PubMed ID: 1507659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
    Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
    Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pravastatin on cholesterol metabolism in Watanabe heritable hyperlipidemic rabbits.
    Amorosa LF; Rozovski SJ; Ananthakrishnan R; Coly E; AlHinai A; Martucci C; Schneider SH; Shimamura T; Khachadurian AK
    Jpn Heart J; 1992 Jul; 33(4):451-63. PubMed ID: 1453550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic aortic coarctation on atherosclerosis and arterial lipid accumulation in the Watanabe hereditary hyperlipidemic (WHHL) rabbit.
    Roux SP; Kuhn H; Lengsfeld H; Morand OH
    Atherosclerosis; 1992 Mar; 93(1-2):123-32. PubMed ID: 1596295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular reactivity during the progression of atherosclerotic plaque. A study in Watanabe heritable hyperlipidemic rabbits.
    Kolodgie FD; Virmani R; Rice HE; Mergner WJ
    Circ Res; 1990 Apr; 66(4):1112-26. PubMed ID: 2317889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits.
    Watanabe N; Ishikawa Y; Okamoto R; Watanabe Y; Fukuzaki H
    Artery; 1987; 14(5):283-94. PubMed ID: 3662844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit--long-term antiatherogenic effect and effects on established plaques.
    Nagano Y; Nakamura T; Matsuzawa Y; Cho M; Ueda Y; Kita T
    Atherosclerosis; 1992 Feb; 92(2-3):131-40. PubMed ID: 1632845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plaque-stabilizing effect of pitavastatin in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Suzuki H; Kobayashi H; Sato F; Yonemitsu Y; Nakashima Y; Sueishi K
    J Atheroscler Thromb; 2003; 10(2):109-16. PubMed ID: 12740485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.